David Henry Mack insider trades: PMV Pharmaceuticals (PMVP) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where David reports to the SEC
Open-market buys and sales
5 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jul 1, 2025 | PMVP | ↓ Sell | 58,411 | $1.06 | $62K | Direct | Jul 3, 2025 (2d) |
| Jul 21, 2021 | PMVP | ↓ Sell | 27,796 | $35.75 | $994K | Direct | Jul 22, 2021 (1d) |
| Jun 28, 2021 | PMVP | ↓ Sell | 204 | $35.53 | $7K | Direct | Jun 29, 2021 (1d) |
| May 21, 2021 | PMVP | ↓ Sell | 14,000 | $35.65 | $499K | Direct | May 24, 2021 (3d) |
| Feb 16, 2011 | ACRX | ↑ Buy | 680,000 | $5.00 | $3.4M | Direct | Feb 18, 2011 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About David Henry Mack's insider trades
David Henry Mack is President and CEO at PMV Pharmaceuticals (PMVP). Since Feb 16, 2011, David has reported 1 open-market purchase worth $3.4M and 4 sales worth $1.6M on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include option exercises (14 filings), grants and awards (10 filings), gifts (3 filings), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every PMVP insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.